Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 131 member C2, pseudogene (FAM131C2P) is a non-coding DNA stretch annotated as a pseudogene[2][5]. Pseudogenes resemble active genes but are usually rendered non-functional by disabling mutations, such as frame shifts or premature stop codons[3]. While some pseudogenes have been shown in general to participate in RNA-based regulatory mechanisms—as microRNA sponges or through antisense competition[1][3]—there is no evidence that FAM131C2P itself is biologically active or clinically relevant as a target. No information currently links it to disease, drug effects, or biomarker status, and it is not considered a molecular target for pharmacology or therapy[2]. If structured data is needed for downstream use, entries for therapeutic relevance and function should be marked as null unless new experimental data becomes available. This target is best classified as a pseudogene, not a protein, receptor, or actionable pharmacological target[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 131 member C2, pseudogene (FAM131C2P).